Abscora is a pioneering biotechnology research company dedicated to transforming cancer treatment. At the forefront of innovation, Abscora develops nanoparticle-based adjuvants that alter the tumor microenvironment to overcome resistance to cancer immunotherapy.
Company Details
- Employees
- 1
- Founded
- 2024
- Address
- 2500 Crosspark Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Coralville, Iowa
- Competitors
- MoodMe, Invisibl Cloud, Society of Pharmacometrics and Health Analytics (Formerly PAGIN), Quant16, The AMR & One Health Lab at Queen's, NSF AI Institute for Artificial Intelligence and Fundamental Interactions (IAIFI), FarrPro, Solitek - Solid Technologies SL, International Society of Pharmacometrics, DELPHARM MONTREAL.
Abscora Inc. Questions
Abscora Inc.'s LinkedIn profile is https://www.linkedin.com/company/abscora-inc
Abscora Inc. has
1 employees.
View email and phone details for 1
employees at Abscora Inc..
Abscora Inc.'s industry is
Biotechnology Research
Abscora Inc.'s top competitors are
Moodme,
Invisibl Cloud,
Society Of Pharmacometrics And Health Analytics (Formerly Pagin),
Quant16,
The Amr & One Health Lab At Queen's,
Nsf Ai Institute For Artificial Intelligence And Fundamental Interactions (Iaifi),
Farrpro,
Solitek - Solid Technologies Sl,
International Society Of Pharmacometrics,
Delpharm Montreal.
Abscora Inc.'s categories are Biotechnology Research
Abscora Inc.'s founding year is 2024
